Site Search
Search Results
May 2012 Monthly Advocacy Update
... certified, it has become clear, with nearly all the votes counted, that Proposition 29 was likely defeated by Big Tobacco's $50 million campaign of deception. Prop 29 would have saved more than 104,000 lives, stopped more than 228,000 kids from smoking and invested more than $500 million ... of volunteers and the millions of families in California impacted by cancer who stood up with us against Big Tobacco. The Society and ACS CAN also extremely grateful to Division and ACS CAN staff for their dedication and hard work. Finally, the American Heart Association, the American ... Health Fund and has consistently opposed attempts to eliminate or divert funding from prevention services. Read the ACS CAN press release . Cost Containment Massachusetts is expected to pass comprehensive legislation in the near future to overhaul the way physicians and hospitals are ...
2019 Advocacy Accomplishments
*/ This report includes key accomplishments from 2019. However, it is not an exhaustive list of all of the advocacy work that ACS CAN staff and volunteers did across the country. For more information on ACS CAN’s advocacy efforts, explore our website. Sustained Investments ... In December 2019, the House of Representatives passed comprehensive drug pricing legislation that included a provision to eliminate this cost-sharing loophole. The Removing Barriers to Colorectal Cancer Screenings Act was one of the most-supported pieces of legislation in Congress, ...
NY to Big Tobacco "We'll Help You Get New Customers"
Statement from Donald Distasio, CEO, American Cancer Society of NY & NJ, regarding slashing of the NYS Tobacco Control Program in the 2011-12 budget agreement. “It’s a good day to be a tobacco lobbyist in Albany. Big cuts demanded by ... of resources. What makes the TCP different? A powerful, wealthy lobby against it that convinces lawmakers the program is a piggy bank that can be smashed when cash is needed to satisfy important constituencies. By cutting the TCP, New Yorkers will see more death, suffering and misery ...
2017 ACS CAN Oklahoma City Cancer Policy Forum
2017 ACS CAN OKC Cancer Policy Forum Cancer Research & Clinical Trials in Oklahoma You are invited to the American Cancer Society Cancer Action Network's ... Oklahoma. Guests will include leading researchers, oncologists, health professionals, citizen-volunteers and health care advocates. There is no cost to attend. Advances in cancer research are fueling the way for better prevention, screening and treatment options. Researchers in Oklahoma received more than $87 million from the National Institutes of Health last year to support their efforts to help keep us healthy and develop better treatments when we are sick. Please join us to hear more ...
2017 Kentucky Legislative Roundup
The 2017 Kentucky Legislative Session has ended. ACS CAN saw a major win (see below) on tobacco cessation legislation! We also saw progress on other critical issues that we will continue to push ... Task Force (USPSTF) for tobacco cessation, including all seven Food and Drug Administration (FDA)-approved medications and all three forms of counseling without cost-sharing or prior authorization. SB 89 passed with overwhelming support, and was signed into law on March 21, 2017! Tobacco Free Schools: ...
Nation 's Top Patient Advocacy Groups Urge United States Senate Committee on Health, Education, Labor and Pensions to Support Investment in Health Prevention
... healthcare system that better incorporates, coordinates and values quality and prevention. Collectively, these organizations represent millions of patients, survivors and families affected by four of the nation’s most prevalent chronic diseases: cancer, diabetes, heart disease and stroke. Americans at risk of developing these deadly and costly diseases can benefit tremendously from proven community interventions, clinical services, early detection and health screenings. The return on investment ... Promotion, and Integrative and Public Health. “Much of the suffering and death from cancer that occurs today, along with the substantial cost we incur of treating advanced disease, could be reduced through evidence-based prevention.” A unified focus on prevention that includes ...
ACTION | It’s Time to Restart Cancer Clinical Trials
As America begins its recovery from the COVID pandemic, there is an important part of our health care system that remains stalled – cancer clinical trials. When COVID struck, federally-funded clinical trials were immediately ... However, the federal grants provided to cancer researchers in 2019 or early 2020 simply didn’t account for a pandemic and the associated costs of having to shut down and then restart research. New specimens must be taken. Tests must be repeated. Additional supplies must be purchased. While ... us in asking Congress to provide funding to restart clinical trials and ensure that potentially lifesaving breakthroughs are not lost. You can send a message to your members of Congress right now using ACS CAN’s easy action form. It takes less than a minute to do, but the impact ...
2021 Policy Forum: Health Equity and Access to Care in Georgia
If we are to achieve the goal of defeating cancer, we must fight to achieve health equity, the just and fair opportunity for everyone to prevent, find, treat and survive cancer – regardless of how much money they make, the color of their skin, their sexual orientation, their gender identity, their disability status, or where they live. This virtual event will focus on health equity and its impact on access to care in the cancer space. ACS CAN will host its annual Georgia Policy Forum on Tuesday Oct. 26 via Zoom at 12:00 pm. This event will bring together key leaders and decision ...
Biomarker Testing in Tennessee
... access to biomarker testing in Tennessee! Welcome! Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Tennessee residents can benefit from this important testing. ... Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid. Biomarker testing is the analysis of a patient’s tissue, blood or other biospecimen for the presence of a biomarker. Policy action is needed to ensure more Tennesseans benefit ...
DeLauro Bill Could Reinvigorate America's Fight Against Cancer
... a bipartisan bill that would create a budget cap adjustment to allow for a funding increase for biomedical research at the National Institutes of Health (NIH). The bill would boost the NIH budget by ten percent for the next two years, followed by a five percent increase in each following ... supported. We hope Rep. DeLauro's bill will prioritize cancer research, because the disease will kill an estimated 589,000 people in America and cost the economy $216 billion this year. As the largest public funder of cancer research, the federal government plays a critical role in our ... further multiplied as private industry leverages basic scientific discovery that translates into lifesaving detection tools and therapies. ACS CAN urges Members of Congress to support this important proposal and make the fight against cancer a national priority. ACS CAN, the nonprofit, ...
Type
- Action (3) Apply Action filter
- Basic page (109) Apply Basic page filter
- Blog Post (85) Apply Blog Post filter
- Event (29) Apply Event filter
- Landing Page (1) Apply Landing Page filter
- Press Release (1141) Apply Press Release filter
- Resource (68) Apply Resource filter
- State Priority (106) Apply State Priority filter
- Update (662) Apply Update filter
Priority Issue
State
- National (232) Apply National filter
- Maine (123) Apply Maine filter
- Massachusetts (120) Apply Massachusetts filter
- New York (117) Apply New York filter
- Vermont (117) Apply Vermont filter
- New Jersey (59) Apply New Jersey filter
- Connecticut (51) Apply Connecticut filter
- California (47) Apply California filter
- Ohio (45) Apply Ohio filter
- Pennsylvania (43) Apply Pennsylvania filter
- Maryland (34) Apply Maryland filter
- North Carolina (33) Apply North Carolina filter
- Michigan (32) Apply Michigan filter
- Florida (29) Apply Florida filter
- Tennessee (26) Apply Tennessee filter
- Kentucky (25) Apply Kentucky filter
- New Mexico (25) Apply New Mexico filter
- West Virginia (25) Apply West Virginia filter
- South Carolina (24) Apply South Carolina filter
- Wyoming (24) Apply Wyoming filter
- Illinois (22) Apply Illinois filter
- Texas (22) Apply Texas filter
- Oklahoma (21) Apply Oklahoma filter
- Georgia (20) Apply Georgia filter
- Missouri (20) Apply Missouri filter
- South Dakota (20) Apply South Dakota filter
- Arizona (19) Apply Arizona filter
- Colorado (19) Apply Colorado filter
- Indiana (18) Apply Indiana filter
- Nevada (18) Apply Nevada filter
- Oregon (18) Apply Oregon filter
- Arkansas (17) Apply Arkansas filter
- Montana (16) Apply Montana filter
- New Hampshire (16) Apply New Hampshire filter
- Rhode Island (16) Apply Rhode Island filter
- North Dakota (15) Apply North Dakota filter
- Alabama (14) Apply Alabama filter
- Idaho (13) Apply Idaho filter
- Utah (13) Apply Utah filter
- Virginia (13) Apply Virginia filter
- Louisiana (12) Apply Louisiana filter
- Minnesota (12) Apply Minnesota filter
- Mississippi (11) Apply Mississippi filter
- Kansas (10) Apply Kansas filter
- Nebraska (10) Apply Nebraska filter
- Washington (10) Apply Washington filter
- Alaska (9) Apply Alaska filter
- District Of Columbia (9) Apply District Of Columbia filter
- Hawaii (9) Apply Hawaii filter
- Delaware (8) Apply Delaware filter
Policy Issue
- Access to Health Care (19) Apply Access to Health Care filter
- Research, Funding and Drug Development (8) Apply Research, Funding and Drug Development filter
- Prevention and Early Detection (7) Apply Prevention and Early Detection filter
- Health Equity (4) Apply Health Equity filter
- Patient Quality of Life (3) Apply Patient Quality of Life filter